Study: Vaccination linked to lower risk of post-COVID

The Swedish innovation model: “There is a paradox”

Setback for Moderna in patent dispute with mRNA competitors

Eli Lilly to build a USD 2.5-billion plant in Germany

Novo Nordisk to invest billions in Danish manufacturing facilities

The Swedish Academy of Sciences: “We have too many researchers”

High biological age is linked to a higher risk of dementia and stroke

Tirzepatide approved for obesity by the FDA – to be branded as Zepbound

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

“A major energy boost for the entire cancer vaccine field”

High-tech companies are increasingly focusing on health

Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease

“You discover one thing – and then 10 new questions arise”

Novo Nordisk buys drug candidate in billion dollar deal

The physician at the tech giant: “Observations in the emergency room made my mind up”

Study names with an attitude – more important than you might think

Rickard Sandberg on this year’s Nobel Prize in Medicine: ”A key discovery”

The first drugs to slow down Alzheimer’s – but what does it mean for patients?

Marie Gårdmark: ”The situation is not satisfactory”

Charlotta Gummeson leaves Sahlgrenska Science Park – “It feels sad and exciting at the same time”

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

Pfizer’s Paxlovid is being tested against post-COVID in a major Swedish study

19 medicines in Sweden are under investigation in a major EMA inquiry

The Swedish government is to increase its investment in cancer care

From the sea of Åland to a self-test for lithium

Samuel Lagercrantz: A special kind of hellishness afflicts post-COVID patients

Heidi Stensmyren is eager for new challenges in the biotech industry

Here are the pharmaceutical companies best prepared for AI

Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell

Bioarctic granted Japanese patent for Parkinson’s disease candidate

“Unfortunately, we are not strong when it comes to conducting clinical trials”

Small robots to deliver pharmaceuticals to the body

Double up for Korbinian Löbmann

CROs in drug development: "We use our expertise to speed up the process

A billion-dollar acquisition makes Novo Nordisk even bigger in obesity

Why the world renown researcher Marc Tessier-Lavigne resigns as Stanford´s president

Uppsala-based company wins important patent dispute – but the decision is subject to appeal